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We present a case of carbapenemase-produc-
ing  blaNDM-1-positive  Salmonella  Kottbus in an 
82-year-old Danish man. The blaNDM-1 was also iden-
tified in  Escherichia coli  and  Citrobacter freundii  in 
the same patient on the same 43 kb IncN2 plasmid, 
suggesting in vivo inter-species plasmid transfer. A 
NCBI BLAST analysis of the plasmid (pAMA003584_
NDM-1) identified 12 highly similar plasmids, all 
originating from east and south-east Asia. This case 
could be the first confirmed case of  blaNDM-1-posi-
tive Salmonella not related to travel outside Europe.
In Denmark, non-typhoidal  Salmonella  (NTS) is 
notifiable by the diagnosing laboratory and  S.  enter-
ica  subsp.  enterica  serovar Kottbus is a rare serovar, 
accounting for ca 1% of all NTS-cases registered over 
the past 20 years (https://statistik.ssi.dk).  S.  Kottbus 
has been isolated from poultry, cattle, pigs and reptiles 
[1] and has been identified in several outbreaks [2-5].
Carbapenems are not first-choice drugs for the treatment 
of  Salmonella. However, the emergence of resistance 
to carbapenems, often last-line antimicrobial agents, 
is a major concern. In human  Salmonella  infections, 
five carbapenemases are of major clinical importance, 
namely  Klebsiella pneumoniae  carbapenemases (KPC; 
class A), New Delhi metallo-β-lactamase (NDM; class 
B), Verona integron-encoded metallo-β-lactamase 
(VIM; class B), and imipenemase (IMP; class B), and 
oxacillinases (OXA e.g. OXA-48; class D) [6].
We present a case of an NDM-1 carbapenemase-pro-
ducing  S.  Kottbus, isolated in a Danish man who did 
not have travel history outside of Europe.
Case report
The patient was an 82-year-old man with a recent 
diagnosis of inoperable lung cancer with no option for 
chemotherapy. In November 2020, he was hospitalised 
because of intermittent fever, abdominal pain, and 
diarrhoea for several weeks. On examination, he had 
tachycardia (112 beats/minute) and a body temperature 
of 37.4°C. Laboratory findings showed leucocytosis 
(34.1 × 109/L; norm: 3.5–10.0) and elevated C-reactive 
protein (265 mg/L; norm: < 8.0). A computed tomogra-
phy scan with contrast revealed bowel wall thickening 
in the left colon, suggestive of an underlying inflamma-
tory or infectious condition. A stool sample taken on 
the day of admission was positive for Clostridioides dif-
ficile toxin B (Xpert C. difficile BT, Cepheid, Sunnyvale, 
California, United States (US)) and oral metronidazole 
treatment was initiated. In another stool sample also 
from the day of admission,  Salmonella  was isolated 
by routine methods and antimicrobial susceptibility 
testing was performed using the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) 
standardised disk diffusion method for Enterobacteral
es (Breakpoint table v10.0) [7]. Surprisingly, the isolate 
was resistant to meropenem (inhibition zone diameter: 
11mm) and the NG-Test CARBA 5 (NG Biotech, Guipry, 
France) [8] was positive for NDM. The stool sam-
ple was also plated on chromID CARBA SMART agar 
(bioMérieux, Marcy l’Etoile, France), showing growth 
of  Escherichia coli  and  Citrobacter freundii; both iso-
lates were NDM-positive with the NG-Test CARBA 5. The 
diarrhoea symptoms subsided after a few days and the 
patient recovered. On day 8, he was discharged and 
treatment with oral metronidazole continued for a total 
of 10 days. After 2 weeks, he died at his home.
A review of the patient’s records clarified that, in 
September 2020, he had been at a resort on the Ionian 
Sea, Greece, for a week-long holiday. The patient and 
his partner stayed at an all-inclusive hotel; both had 
an onset of diarrhoea 2 days after arrival. The patient 
had many loose stools so he visited an outpatient 
clinic where he received intravenous rehydration 
and antibiotic therapy with oral cefuroxime. After the 
patient returned to Denmark, the diarrhoea symptoms 
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subsided but the patient was hospitalised a few days 
later with kidney failure; a rectal swab taken as part of 
screening procedures for multidrug-resistant bacteria 
were negative. Throughout September and October, the 
patient was hospitalised for chronic kidney failure, and 
was eventually diagnosed with inoperable lung cancer. 
He was dialysed and received different antibiotic regi-
mens, including oral metronidazole for recurrent diar-
rhoea. However, a stool sample for enteric pathogenic 
bacteria was not taken until the final hospital stay in 
November.
Serotyping and genomic analysis at the 
National Reference Laboratory
In 2018, the Danish Health Authority added carbapen-
emase-producing organisms (CPO) to the list of noti-
fiable bacteria, and the Danish National Reference 
Laboratory (Statens Serum Institut (SSI)) carries 
out whole genome sequencing of all CPO isolates. 
At SSI, the isolate from the patient was serotyped 
as S. Kottbus based on the Kauffmann-White-Le Minor 
scheme, which was later verified using the sequence 
data to predict the serotype.
For short-read sequencing of the NDM-1-
producing  S.  Kottbus,  E. coli  and  C. freundii, DNA 
was extracted using DNeasy Blood and Tissue Kit 
(Qiagen, Hilden, Germany) and Nextera XT DNA Library 
Preparation Kit (Illumina, San Diego, California, US) 
was used before sequencing with a 2 × 151 bp paired-
end Mid-Output kit (Illumina). The sequence reads 
are available from the European Nucleotide Archive 
(ENA; accession number: ERS6246687). For nanopore 
sequencing, DNA was extracted with the GenFind v3 
(Beckman Coulter, Indianapolis, Indiana, US) using a 
DynaMag-2 magnet (Thermo Fisher Scientific, Waltham, 
Massachusetts, US). A library was prepared using the 
Rapid Barcoding Sequencing Kit (SQK-RBK004) and 
sequenced in a R10.3 flow cell (FLO-MIN111) with a 
MinION Mk1B (Oxford Nanopore Technologies, Oxford, 
United Kingdom (UK)). Using Guppy v4.2.2 (Oxford 
Nanopore Technologies), raw fast5 reads were base-
called to fastq format in ‘high-accuracy’ configura-
tion, demultiplexed and quality filtered to minimum 
q8. Then Illumina-Nanopore hybrid de novo genome 
assembly was run with Unicycler v0.4.8-beta [9].
The  E. coli  was identified as sequence type (ST)399 
and  C. freundii  as ST18. The  blaNDM-1 was identified 
in all three isolates placed on the same 43 kb IncN2 
plasmid (pAMA003584_NDM-1; GenBank accession 
number: MZ004973), identified by PlasmidFinder v2.1 
[10], as shown in Figure 1.
A National Center for Biotechnology Information 
(NCBI) Basic Local Alignment Tool (BLAST) analysis of 
pAMA003584_NDM-1 identified 12 highly similar plas-
mids, all originating from east and south-east Asia 
(Table 1).
Ethical Statement
A signed informed consent for publication from the 
deceased’s partner was obtained before submitting.
Discussion
In the European Union (EU)/European Economic Area 
(EEA), the notification rate of NTS was 20 cases per 
100,000 inhabitants in 2019 [11]. In Denmark, the 
notification rate for NTS was almost identical (19.3 
cases/100,000 inhabitants) in 2019, while the lowest 
rates were reported by Cyprus, Greece, Ireland, Italy, 
Portugal, and Romania (≤ 7.1 cases/100,000 inhabit-
ants) [11].
Here we present the first confirmed case of  blaNDM-
1-positive  S.  Kottbus not related to travel outside 
Europe. The  blaNDM-1 gene was also identified in  E. 
coli and C. freundii on the same 43 kb IncN2 plasmid, 
suggesting an inter-species transfer of the  blaNDM-
1-carrying IncN2 plasmid in vivo.
The first NDM-producing NTS case, published in 2011, 
was a 60-year-old American man who was transferred 
from India to a hospital in the US where  blaNDM-
1-positive  Salmonella  Senftenberg was isolated from 
a perirectal surveillance culture [12]. Following this, 
other  blaNDM-1-positive human NTS cases were 
described in connection to India, Pakistan and China, 
as reviewed by Fernández et al [6]. In 2015, Day et al. 
reported an isolate of  S.  Senftenberg from the UK, 
obtained in 2008 from faeces in an outpatient with 
unknown travel history. The isolate was resistant to 
Figure
Map of the blaNDM-1-carrying 43 kb IncN2 plasmid 
pAMA003584_NDM-1 from an isolate of Salmonella 










GenBank accession number: MZ004973. The location of the 
blaNDM-1 gene is shown in blue.
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ertapenem, but susceptible to meropenem and har-
boured the  blaNDM-1 gene on a 53 kb IncX3 plasmid 
nearly identical (99.7%) to an IncX3-type  blaNDM-1 
plasmid from a  Raoultella planticola  detected in 
China [13]. During 2019, only a single carbapenem-
resistant  Salmonella  Typhimurium var. O:5-negative-
carrying  blaOXA-48 was reported in the EU/EEA. In 
2018, two isolates of  Salmonella  Kentucky (OXA-48-
producing), and single isolates of Salmonella Corvallis 
(OXA-48-producing),  Salmonella  Rissen (KPC-
producing) and  Salmonella  Typhimurium 
(VIM-producing) were identified, whereas no NDM-
producing Salmonella were reported [14].
In the case presented here, we identified three bac-
teria in the same patient, all of which harboured the 
same carbapenem-resistance gene. Carbapenemase 
acquisition by an NTS from other Enterobacteriaceae in 
immunocompromised patients in a healthcare context 
has been suggested [6]. According to the patient’s 
partner, other guests at the resort also had diarrhoea; 
we can speculate that this patient may have eaten con-
taminated food at the resort in Greece, but the exact 
source of the  blaNDM-1 plasmid remains unknown. 
Furthermore, we can only hypothesise which of the 
three bacteria first obtained the  blaNDM-1 plasmid. 
Denmark has a low prevalence of carbapenemase-pro-
ducing bacteria [15] and the fact that S. Kottbus is very 
rare in Denmark also suggests that the three bacteria 
had ‘spent time together’ in vivo. During the autumn, 
the patient was hospitalised and diagnosed with 
terminal lung cancer. He received different antibiotic 
regimens so, on the other hand, we cannot rule out an 
acquisition of the IncN2 plasmid by one of the three 
bacteria in Denmark.
Conclusions
We describe the first case of  blaNDM-1-positive  S. 
Kottbus located on a 43 kb IncN2-plasmid from an 
82-year-old man with terminal lung cancer detected in 
Denmark. The plasmid was also found in E. coli and C. 
freundii  from the same patient,  suggesting horizontal 
gene transfer. The patient had no known travel history 
outside Europe and could be the first confirmed 
case of  blaNDM-1-positive  Salmonella  not related to 
travel outside Europe. Our finding underscores the 
importance of remaining vigilant for the potential risk 
of emerging resistance strains. In sum, we find any 
potential spread of NDM-1-producing NTS worrisome 
and emphasize the need for antimicrobial resistance 
surveillance in Europe, especially in countries where 
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